LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,227,521 | -1.9% | 271,364 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $18,576,525 | -15.3% | 269,108 | -40.8% | 0.00% | 0.0% |
| Q1 2023 | $21,934,507 | +85.4% | 454,884 | +92.0% | 0.00% | +100.0% |
| Q4 2022 | $11,829,992 | -26.5% | 236,979 | -39.9% | 0.00% | -50.0% |
| Q3 2022 | $16,085,000 | +7.1% | 394,205 | +44.4% | 0.00% | 0.0% |
| Q2 2022 | $15,014,000 | +58.9% | 272,990 | +5.0% | 0.00% | +100.0% |
| Q1 2022 | $9,449,000 | +108.3% | 259,995 | +167.1% | 0.00% | – |
| Q4 2021 | $4,537,000 | +1990.8% | 97,353 | +2173.5% | 0.00% | – |
| Q3 2021 | $217,000 | -62.5% | 4,282 | -69.7% | 0.00% | – |
| Q2 2021 | $579,000 | +96.3% | 14,124 | +39.1% | 0.00% | – |
| Q1 2021 | $295,000 | +14650.0% | 10,154 | +18361.8% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |